Japan Diabetes Market is expected to be USD 3.39 Billion by 2028
According to Renub Research's latest report, "Japan Diabetes Market, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis" the Japan Diabetes Market to grow with a CAGR of 2.73% from 2022 to 2028. Japan has one of the largest older populations in the world, which is more susceptible to the onset of type 2 diabetes. Diabetes is a no infectious disease caused by high blood glucose levels. Over time, it can lead to serious heart, brain, blood vessels, eye, kidney, and nerve damage. With a rising aging population, lifestyle changes, increasing overweight, and the prevalence of diabetic patients increasing, have significantly boosted the market. According to World Health Organisation, Diabetes Mellitus deaths in Japan reached 5,433 deaths.
Rapidly Increa...